Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Martini

Showing results (481-490 of 549) with videos related to

Pageof 55
Sort By:
Arthritis Research & Therapy|January 25, 2017
Early changes in gene expression and inflammatory proteins in systemic juvenile idiopathic arthritis patients on canakinumab therapyArndt H Brachat, Alexei A Grom, Nico Wulffraat, et al.
Annals of the Rheumatic Diseases|May 20, 2017
ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national studyRoberta Caorsi, Federica Penco, Alice Grossi, et al.
Journal of the American Society of Nephrology : JASN|May 3, 2014
Glomerular autoimmune multicomponents of human lupus nephritis in vivo: α-enolase and annexin AIMaurizio Bruschi, Renato Alberto Sinico, Gabriella Moroni, et al.
Annals of the Rheumatic Diseases|July 24, 2020
Safety and efficacy of intravenous belimumab in children with systemic lupus erythematosus: results from a randomised, placebo-controlled trialHermine I Brunner, Carlos Abud-Mendoza, Diego O Viola, et al.
Annals of the Rheumatic Diseases|February 1, 2015
Evidence-based provisional clinical classification criteria for autoinflammatory periodic feversSilvia Federici, Maria Pia Sormani, Seza Ozen, et al.
Arthritis Care & Research|July 3, 2010
Abatacept improves health-related quality of life, pain, sleep quality, and daily participation in subjects with juvenile idiopathic arthritisNicolino Ruperto, Daniel J Lovell, Tracy Li, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 13, 2026
Pharmacokinetics, effectiveness and safety of certolizumab pegol in children and adolescents with active juvenile idiopathic arthritis: 9+-year results from a multicenter, open-label studyHermine I Brunner, Lyudmila Grebenkina, Irina Nikishina, et al.
Lancet (London, England)|February 7, 2017
Intra-articular corticosteroids versus intra-articular corticosteroids plus methotrexate in oligoarticular juvenile idiopathic arthritis: a multicentre, prospective, randomised, open-label trialAngelo Ravelli, Sergio Davì, Giulia Bracciolini, et al.
JAMA|April 8, 2010
Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trialDirk Foell, Nico Wulffraat, Lucy R Wedderburn, et al.
Annals of the Rheumatic Diseases|May 20, 2014
Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trialHermine I Brunner, Nicolino Ruperto, Zbigniew Zuber, et al.
Pageof 55

Showing results (481-490 of 549) with videos related to

Sort By:
Pageof 55
Arthritis Research & Therapy|January 25, 2017
Early changes in gene expression and inflammatory proteins in systemic juvenile idiopathic arthritis patients on canakinumab therapyArndt H Brachat, Alexei A Grom, Nico Wulffraat, et al.
Annals of the Rheumatic Diseases|May 20, 2017
ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national studyRoberta Caorsi, Federica Penco, Alice Grossi, et al.
Journal of the American Society of Nephrology : JASN|May 3, 2014
Glomerular autoimmune multicomponents of human lupus nephritis in vivo: α-enolase and annexin AIMaurizio Bruschi, Renato Alberto Sinico, Gabriella Moroni, et al.
Annals of the Rheumatic Diseases|July 24, 2020
Safety and efficacy of intravenous belimumab in children with systemic lupus erythematosus: results from a randomised, placebo-controlled trialHermine I Brunner, Carlos Abud-Mendoza, Diego O Viola, et al.
Annals of the Rheumatic Diseases|February 1, 2015
Evidence-based provisional clinical classification criteria for autoinflammatory periodic feversSilvia Federici, Maria Pia Sormani, Seza Ozen, et al.
Arthritis Care & Research|July 3, 2010
Abatacept improves health-related quality of life, pain, sleep quality, and daily participation in subjects with juvenile idiopathic arthritisNicolino Ruperto, Daniel J Lovell, Tracy Li, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 13, 2026
Pharmacokinetics, effectiveness and safety of certolizumab pegol in children and adolescents with active juvenile idiopathic arthritis: 9+-year results from a multicenter, open-label studyHermine I Brunner, Lyudmila Grebenkina, Irina Nikishina, et al.
Lancet (London, England)|February 7, 2017
Intra-articular corticosteroids versus intra-articular corticosteroids plus methotrexate in oligoarticular juvenile idiopathic arthritis: a multicentre, prospective, randomised, open-label trialAngelo Ravelli, Sergio Davì, Giulia Bracciolini, et al.
JAMA|April 8, 2010
Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trialDirk Foell, Nico Wulffraat, Lucy R Wedderburn, et al.
Annals of the Rheumatic Diseases|May 20, 2014
Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trialHermine I Brunner, Nicolino Ruperto, Zbigniew Zuber, et al.
Pageof 55